跳至主要内容
临床试验/NL-OMON43572
NL-OMON43572已完成4 期

Median Local Anaesthetic dose (MLAD) of Intrathecal Bupivacaine in anterior supine intermuscular total hip arthroplasty - ED50 of Intrathecal Bupivacaine in Total Hip Arthroplasty

Reinier de Graaf Groep0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - ASA I to III
  • - 18y or older
  • - Primary uncemented THA-ASI
  • - Willing to participate
  • - Speaking Dutch language

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Hypersensitivity to local anesthetics or any of the other excipients of Bupivacaine
  • - Any other contraindications relate to intrathecal anesthesia
  • - CNS disease, e.g. meningitis, tumor, poliomyelitis, cerebral haemorrhage
  • - Spinal stenosis and diseases or recent trauma to the cervical column
  • - Pernicious anemia with symptoms related to cervical degradation
  • - Pyogenic infections of the skin close to the injection site
  • - Cardiogenic or hypovolemic shock
  • - Disturbance in coagulation or treatment with anti-coagulants
  • - Patient is participating in a medicinal study
  • - Noncompliant to intrathecal anesthsia
  • - Patients who are incompetent to decide

研究者

发起方
Reinier de Graaf Groep

相似试验